Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1597796

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1597796

Surgical Simulation Market by Surgery Type (Cardiac Surgery/Interventional Cardiology, Gastroenterology, Neurosurgery), End-use (Hospitals, Specialty Centres) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Surgical Simulation Market was valued at USD 396.80 million in 2023, expected to reach USD 448.62 million in 2024, and is projected to grow at a CAGR of 13.54%, to USD 965.40 million by 2030.

Surgical simulation refers to the use of advanced technology, such as virtual reality (VR), augmented reality (AR), and high-fidelity mannequins, to mimic surgical procedures for training and skills enhancement. The growing necessity of surgical simulators is driven by the increasing emphasis on patient safety, the need for reducing medical errors, and the benefits of practicing complex surgeries in a risk-free environment. These simulators find critical applications in medical schools, hospitals, and training centers, facilitating the realistic practice of surgical procedures ranging from minimally invasive techniques to major surgeries. The end-use scope spans across education sectors, healthcare training institutions, and hospitals seeking to bolster staff proficiency and operational readiness. Key growth influencers include technological advancements in simulation tools, rising healthcare investments, and the global surge in demand for skilled surgical professionals due to aging populations and chronic disease prevalence. Opportunities lie in the integration of AI and machine learning for personalized training modules and the expansion of online, cloud-based simulation platforms to cater to remote learning needs. Companies could capitalize on these opportunities by forming strategic partnerships with tech firms and educational institutions to enhance simulation offerings. However, limitations such as high costs, requirement for continuous updates, and limited access in emerging economies can pose challenges to widespread adoption. Additionally, the need for specialized technical expertise for setup and operation can be a barrier in resource-constrained settings. Innovation should focus on reducing the cost of simulation technologies, ensuring scalability, and incorporating more realistic haptic feedback systems to improve tactile experiences. The market is characterized by rapid technological advancements and intense competition among key players striving for innovation. Staying attuned to evolving technological trends and regulatory standards will be crucial for businesses aiming to establish a robust foothold in this dynamic market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 396.80 million
Estimated Year [2024] USD 448.62 million
Forecast Year [2030] USD 965.40 million
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Surgical Simulation Market

The Surgical Simulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferating chronic and acute disease requiring surgical procedures
    • Prevalence of aging population and increase in number of surgical procedures
    • Rising preference for minimally invasive surgical procedures
  • Market Restraints
    • Need for regular updation and high maintenance cost
  • Market Opportunities
    • Availability of advanced healthcare infrastructure and favorable medical insurance and reimbursement scenario
    • Acceptance of 3D printing in surgical simulation
  • Market Challenges
    • Lack of efficacy of simulation of new drug

Porter's Five Forces: A Strategic Tool for Navigating the Surgical Simulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Surgical Simulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Surgical Simulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Surgical Simulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Surgical Simulation Market

A detailed market share analysis in the Surgical Simulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Surgical Simulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Surgical Simulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Surgical Simulation Market

A strategic analysis of the Surgical Simulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Simulation Market, highlighting leading vendors and their innovative profiles. These include 3B Scientific GmbH, 3D Systems, Inc., CAE Inc., DiaMedical USA, Gaumard Scientific Company, Inc., Laerdal Medical AS, Limbs & Things, Mentice AB, Simendo B.V., Simulab Corporation, Startasys Ltd., VirtaMed AG, Virti, Vosaic, and VRmagic Holding AG.

Market Segmentation & Coverage

This research report categorizes the Surgical Simulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Type, market is studied across Cardiac Surgery/Interventional Cardiology, Gastroenterology, Neurosurgery, Oncology Surgery, Orthopedic Surgery, Reconstructive Surgery, and Transplants.
  • Based on End-use, market is studied across Hospitals and Specialty Centres.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-3A2E844FD4D9

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferating chronic and acute disease requiring surgical procedures
      • 5.1.1.2. Prevalence of aging population and increase in number of surgical procedures
      • 5.1.1.3. Rising preference for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Need for regular updation and high maintenance cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of advanced healthcare infrastructure and favorable medical insurance and reimbursement scenario
      • 5.1.3.2. Acceptance of 3D printing in surgical simulation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of efficacy of simulation of new drug
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Surgical Simulation Market, by Surgery Type

  • 6.1. Introduction
  • 6.2. Cardiac Surgery/Interventional Cardiology
  • 6.3. Gastroenterology
  • 6.4. Neurosurgery
  • 6.5. Oncology Surgery
  • 6.6. Orthopedic Surgery
  • 6.7. Reconstructive Surgery
  • 6.8. Transplants

7. Surgical Simulation Market, by End-use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Centres

8. Americas Surgical Simulation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Surgical Simulation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Surgical Simulation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3B Scientific GmbH
  • 2. 3D Systems, Inc.
  • 3. CAE Inc.
  • 4. DiaMedical USA
  • 5. Gaumard Scientific Company, Inc.
  • 6. Laerdal Medical AS
  • 7. Limbs & Things
  • 8. Mentice AB
  • 9. Simendo B.V.
  • 10. Simulab Corporation
  • 11. Startasys Ltd.
  • 12. VirtaMed AG
  • 13. Virti
  • 14. Vosaic
  • 15. VRmagic Holding AG
Product Code: MRR-3A2E844FD4D9

LIST OF FIGURES

  • FIGURE 1. SURGICAL SIMULATION MARKET RESEARCH PROCESS
  • FIGURE 2. SURGICAL SIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SURGICAL SIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SURGICAL SIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SURGICAL SIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SURGICAL SIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SURGICAL SIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SURGICAL SIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY CARDIAC SURGERY/INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY TRANSPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SPECIALTY CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SURGICAL SIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. SURGICAL SIMULATION MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!